Table GPSurvey-5. Last month prevalence of drug use (percentage) among all adults (15-64 years old) in nationwide surveys among the general population

	Country and geographical area	Ref.	Year	Sample size	Cannabis	Cocaine	Amphet-amines	Ecstasy	Hallucin-ogens	LSD

	Belgium
	Vlanderen (Brussels excluded)	⁽¹⁾	1994	2259
	French Community	⁽²⁾	1996-97	976
	French Community	⁽³⁾	1998-99	1108
	French Community	⁽⁴⁾	2000	694	3.8
	National coverage (Flemish, Wallon and Brussels region)	⁽⁵⁾	2001	7347	2.7		0.3
	Czech Republic
	National	⁽¹⁾	2002	2526
	Denmark
	National	⁽¹⁾	1990	2000
	National	⁽²⁾	1994
	National	⁽³⁾	2000	11825	2.8	0.3	0.3	0.2	0.2	0.1
	Germany
	Western Germany	⁽¹⁾	1990
	East Germany	⁽²⁾	1990
	Old Länder (W. Germany) and New Länder (E. Germany)	⁽³⁾	1995	7833	2.8	0.4	0.3	0.5	0.2
	Old Länder (W. Germany) and New Länder (E. Germany)	⁽⁴⁾	1997	8019	2.8	0.3	0.2	0.3	0.0

	National	⁽⁵⁾	2000	8139	3.3	0.2	0.2	0.3	0.1	0.1
	Estonia
	National	⁽¹⁾	1998	2317	2.0
	Greece
	Athens	⁽¹⁾	1993	2103
	Greece except Aegean and Ionian Islands	⁽²⁾	1998	3398	2.3	0.2	0.0	0.0	0.1
	Spain
	National	⁽¹⁾	1995	8888
	National	⁽²⁾	1997	12515	4.0	0.8	0.2	0.2	0.2
	National	⁽³⁾	1999	12234	4.5	0.8	0.2	0.5	0.2
	National	⁽⁴⁾	2001	14113	6.8	1.4	0.6	0.8	0.2
	France
	National	⁽¹⁾	1992	2099
	Metropolitan France	⁽²⁾	1995	1787
	National	⁽³⁾	1999	1742
	National	⁽⁴⁾	2000	11317	4.3	0.1	0.1	0.1		0.1
	Metropolitan France	⁽⁵⁾	2002	1745
	Ireland
	National	⁽¹⁾	1998	na	5.1
	National	⁽²⁾	1998	826
	National	⁽³⁾	2000	907
	National	⁽⁴⁾	2002-03	4925	2.6	0.3	0.2	0.3		0.0
	Italy
	National	⁽¹⁾	2001	6032	4.4	0.7	0.0	0.2	0.2	0.0
	Latvia
	National	⁽¹⁾	2003		1.8	0.1	0.5	0.3	0.3	0.3
	Luxembourg
	National (representative regional communities)	⁽¹⁾	1998	na	4.0	0.2		0.0	0.8	0.0
	Hungary
	National	⁽¹⁾	2001	2359	1.1	0.1	0.3	0.3	0.1	0.1
	Netherlands
	National	⁽¹⁾	1997-98	17590	3.0	0.3	0.1	0.3	0.1
	National	⁽²⁾	2000-01	14045	3.7	0.5	0.3	0.6	0.1	0.0
	Poland
	National	⁽¹⁾	2002		1.3	0.1	0.2	0.2	0.1	0.0
	Portugal
	National	⁽¹⁾	2001	14184	2.4	0.1	0.1	0.2		0.0
	Slovakia
	National	⁽¹⁾	2002	1405	2.7	0.0	0.1	0.1	0.0
	Finland
	National	⁽¹⁾	1992	3457	0.3
	National	⁽²⁾	1996	3009	0.6
	National	⁽³⁾	1998	2568	1.0	0.1	0.1	0.2
	National	⁽⁴⁾	2000	1677	0.7	0.1	0.1	0.1		0.1
	National	⁽⁵⁾	2002	2377	1.1	0.0	0.2	0.1		0.0
	Sweden
	National	⁽¹⁾	1994	806
	National	⁽²⁾	1996	1136
	National	⁽³⁾	1998	1359	0.2	0.0	0.1	0.0
	National	⁽⁴⁾	2000	1750	0.2	0.0	0.1	0.0		0.0
	United Kingdom
	England and Wales	⁽¹⁾	1994	9645	4.9	0.2	1.0	0.4	0.5	0.5
	England and Wales	⁽²⁾	1996	10935	5.5	0.3	1.6	0.7	0.4	0.3
	England and Wales	⁽³⁾	1998	9984	6.1	0.5	1.4	0.5	0.1	0.1
	England and Wales	⁽⁴⁾	2000	13018	6.4	0.8	0.9	0.9	0.3	0.1
	England and Wales	⁽⁵⁾	2001-02	20165	6.6	0.9	0.7	1.1	0.2	0.1
	England and Wales	⁽⁶⁾	2002-03	23586	6.7	0.9	0.6	0.9	0.2	0.1
	Northern Ireland	⁽⁷⁾	2002-03	3517	2.9	0.1	0.2	0.5	0.1	0.0
	Norway
	National	⁽¹⁾	1999	1803	2.4	0.0	0.4	0.2

Notes:
This table aims to present national surveys. Exceptionally some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimaties for whole countries (or big regions with urban and rural areas). Athens was included as reference point for 1993 survey.
In surveys with small sample sizes results should be interpreted with caution.
Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.
For methods and definitions see [Methods and definitions - Prevalence and patterns of drug use in the general population].
For survey methods see [Table GPSurvey-1 Part (ii) Survey methods].

Sources: See [Table GPSurvey-1 Part(iii) Sources].

Download